Targeting α-synuclein as a therapy for Parkinson’s disease: strategies in the pipeline Published 2022-04-28 Download video MP4 360p Download video MP4 720p Recommendations 02:47 α-synuclein & Parkinson's disease: moving away from anti-α-synuclein approaches? 03:01 The value of alpha-synuclein as a putative target for therapeutic intervention in synucleinopathies 04:31 Understanding Parkinson's disease 04:42 CNM-Au8 improves visual function in MS: insights from the VISIONARY-MS trial 01:40 An update on biomarkers for use in Parkinson’s Disease 01:25 The mechanism of action of CNM-Au8 and its potential in various neurodegenerative diseases 18:40 Matthew Perry's Death From Ketamine Explained (Is It Safe For You?) 09:51 Psychiatric Interviews for Teaching: Mania 14:45 AssistMS: testing the value of an AI tool for MRI scan interpretation in clinical practice 1:03:30 Risk Factors for Amyotrophic Lateral Sclerosis: Cyanobacteria and Others 01:50 Exploring the use of stem cell therapies for patients with MS 07:45 AI to improve recognition of stroke symptoms in calls to emergency medical services 04:06 Positive results 2024: The first-ever human trial with Stem Cell therapy for Parkinson's disease 02:09 3D visualization of disease burden in multiple sclerosis 04:42 Stroke Service Tracker data shows major successes and challenges in European stroke care 04:11 Raising awareness of the misuse of stem cell therapies in neurology 08:03 Distinguishing true relapses from pseudo-relapses in MS: the impact on clinical trial readouts 05:31 The Lancet commission on epilepsy: a practical guide for non-specialists 01:39 Evidence for metabolic dysfunction in migraine 29:03 AMA #15: Fluoride Benefits/Risks & Vagus Nerve Stimulation Similar videos 1:18:10 Alpha-synuclein as a therapeutic target for Parkinson’s disease: challenges and opportunities 01:21 Investigating α-synuclein aggregation as a therapeutic target in Parkinson’s disease 46:48 What's in the Pipeline for Parkinson's? 04:31 Is α-synuclein a useful therapeutic target in Parkinson's disease? 02:26 Alpha-synuclein as a therapeutic target for Parkinson's disease 56:50 Updates in Therapeutics for Parkinson’s Disease 38:41 Detecting and Targeting Alpha Synuclein: Are We on a Path Toward a Cure for Parkinson's? 1:00:15 Detecting and Targeting Alpha Synuclein 50:19 Parkinson's Disease Therapeutic Pipeline - Guest Speaker - UF PD Symposium 2023 1:08:05 What’s in the Parkinson's Disease Pipeline? Gene and Cell Therapies 03:30 Advancements in cell therapies for Parkinson’s disease 02:12 Key clinical trials of disease modifying therapies in Parkinson's disease 58:54 Disease-modifying and Symptomatic Therapies in the Pipeline - Updates in PD 1:03:19 VES: The latest medications and what is in the pipeline by Dr. Ellenbogen - 2.21.23 27:27 Parkinson Disease Research Updates 2023 | EMPOWER U Program 2023 59:57 Webinar: "New Treatments in Testing to Slow or Stop Parkinson's" November 2019 1:00:15 What’s in the Parkinson’s Pipeline? Medical Therapies 21:57 Genetic Mutations in Parkinson's Disease | 2019 Udall Center Research Symposium More results